Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.
暂无分享,去创建一个
R. Jaenisch | E. Moran | A. Meissner | Eveline J. Steine | H. Linhart | Haijiang Lin | S. Gokhale | Yasuhiro Yamada | Timothy He | M. Ehrich | Grace Lo | Erika Cantu
[1] C. Allis,et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.
[2] T. Mikkelsen,et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.
[3] R. Curley,et al. Mitotic recombination and uniparental disomy in Beckwith-Wiedemann syndrome. , 2007, Genomics.
[4] M. Fraga,et al. The Polycomb group protein EZH2 directly controls DNA methylation , 2007, Nature.
[5] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[6] Zohar Yakhini,et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.
[7] P. Laird,et al. Epigenetic stem cell signature in cancer , 2007, Nature Genetics.
[8] Kelly M. McGarvey,et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.
[9] H. Mori,et al. Multistep carcinogenesis of the colon in ApcMin/+ mouse , 2007, Cancer science.
[10] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[11] A. Cooney,et al. Differential Recruitment of Methylated CpG Binding Domains by the Orphan Receptor GCNF Initiates the Repression and Silencing of Oct4 Expression , 2006, Molecular and Cellular Biology.
[12] A. Paoloni-Giacobino,et al. Specific Differentially Methylated Domain Sequences Direct the Maintenance of Methylation at Imprinted Genes , 2006, Molecular and Cellular Biology.
[13] S. Leung,et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer , 2006, Nature Genetics.
[14] Richard A Young,et al. Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.
[15] Rolf Ohlsson,et al. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[17] J. Zeitlinger,et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.
[18] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[19] Lung-Ji Chang,et al. CpG Sites Preferentially Methylated by Dnmt3a in Vivo* , 2006, Journal of Biological Chemistry.
[20] R. Jaenisch,et al. Dnmt3b Deletion of Suppression of Intestinal Neoplasia By , 2006 .
[21] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[22] I. Simon,et al. Evidence for an instructive mechanism of de novo methylation in cancer cells , 2006, Nature Genetics.
[23] Rudolf Jaenisch,et al. Efficient method to generate single‐copy transgenic mice by site‐specific integration in embryonic stem cells , 2006, Genesis.
[24] A. Feinberg,et al. The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.
[25] John K Field,et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Jaenisch,et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. J. Driscoll,et al. Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus , 2005, Nucleic acids research.
[28] W. Lam,et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.
[29] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[30] A. Feinberg,et al. Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.
[31] E. Li,et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting , 2004, Nature.
[32] Wei Dong Chen,et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.
[33] A. Schatzkin,et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. , 2004, Journal of the National Cancer Institute.
[34] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[35] Yvonne Wallis,et al. The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.
[36] B. Horsthemke,et al. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma , 1994, Human Genetics.
[37] B. Horsthemke,et al. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma , 1989, Human Genetics.
[38] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[39] P. Froment,et al. The Insulin-like Growth Factor Axis in Cell Cycle Progression , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[40] E. Li,et al. Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b , 2003, Molecular and Cellular Biology.
[41] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[42] R. Jaenisch,et al. Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.
[43] A. Feinberg,et al. Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.
[44] T. Bestor. Unanswered Questions about the Role of Promoter Methylation in Carcinogenesis , 2003, Annals of the New York Academy of Sciences.
[45] M. Robert,et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.
[46] Takuji Tanaka,et al. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. , 2002, Cancer research.
[47] En Li,et al. A Novel Dnmt3a Isoform Produced from an Alternative Promoter Localizes to Euchromatin and Its Expression Correlates with Activede Novo Methylation* , 2002, The Journal of Biological Chemistry.
[48] C. Jomary,et al. Secreted Frizzled-related proteins: searching for relationships and patterns. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[49] R. Jaenisch,et al. Dnmt1 Overexpression Causes Genomic Hypermethylation, Loss of Imprinting, and Embryonic Lethality , 2002, Molecular and Cellular Biology.
[50] Daiya Takai,et al. Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Whitehead,et al. Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression. , 2001, Gastroenterology.
[52] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[53] J. Herman,et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.
[54] S. Baylin,et al. Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.
[55] J. Herman,et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.
[56] Shirley M. Tilghman,et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus , 2000, Nature.
[57] G. Felsenfeld,et al. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.
[58] A. Hassan,et al. Insulin-like Growth Factor II Supply Modifies Growth of Intestinal Adenoma in ApcMin/+ Mice , 2000 .
[59] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[60] C. Walsh,et al. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation , 1998, Nature Genetics.
[61] E. Li,et al. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.
[62] J. Herman,et al. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. , 1998, Cancer research.
[63] W. Held,et al. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice. , 1997, Cancer research.
[64] R. Weinberg,et al. Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.
[65] J. Herman,et al. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[66] K. Kinzler,et al. Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.
[67] P. Crain. Analysis of 5-methylcytosine in DNA by isotope dilution gas chromatography-mass spectrometry. , 1990, Methods in enzymology.
[68] S. Baylin,et al. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. , 1986, Cancer research.
[69] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.